HIV-1-infected And/or Immune-activated Macrophages Regulate Astrocyte CXCL8 Production Through IL-1beta and TNF-alpha: Involvement of Mitogen-activated Protein Kinases and Protein Kinase R
Overview
Authors
Affiliations
Monocyte infiltration is an important pathogenic event in human immunodeficiency virus type one (HIV-1) associated dementia (HAD). CXCL8 (Interleukin 8, IL-8), a CXC chemokine that elicits chemotaxis of neutrophils, has recently been found to recruit monocytes or synergistically enhance CCL2-mediated monocyte migration. In this report, we demonstrate CXCL8 levels in the cerebrospinal fluid of HAD patients are higher than HIV-1 seropositive patients without neurological impairment. The underlying mechanisms regulating CXCL8 production during disease are not completely understood. We investigated the role of HIV-1-infected and immune-competent macrophages, the principal target cell and mediator of neuronal injury in HAD, in regulating astrocyte CXCL8 production. Immune-activated and HIV-1-infected human monocyte-derived-macrophages (MDM) conditioned media (MCM) induced production of CXCL8 by human astrocytes. This CXCL8 production was dependent on MDM IL-1beta and TNF-alpha production following viral and immune activation. CXCL8 production was reduced by inhibitors for mitogen-activated protein kinases (MAPKs), including p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinases (ERK1/2). Moreover, prolonged IL-1beta or TNF-alpha treatment activated double-stranded RNA-activated protein kinase (PKR). Inhibition of PKR prevented elevated CXCL8 production in astrocytes. We conclude that IL-1beta and TNF-alpha, produced from HIV-1-infected and immune-competent macrophages, are critical in astrocyte CXCL8 production. Multiple protein kinases, including p38, JNK, ERK1/2, and PKR, participate in the inflammatory response of astrocytes. These observations will help to identify effective therapeutic strategies to reduce high-levels of CXCL8-mediated CNS inflammation during HAD.
Neuropathogenesis of HIV and emerging therapeutic targets.
Siddiqui A, He C, Lee G, Figueroa A, Slaughter A, Robinson-Papp J Expert Opin Ther Targets. 2022; 26(7):603-615.
PMID: 35815686 PMC: 9887458. DOI: 10.1080/14728222.2022.2100253.
Mielnicka A, Michaluk P Biomolecules. 2021; 11(9).
PMID: 34572580 PMC: 8471187. DOI: 10.3390/biom11091367.
HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins.
Jadhav S, Nema V Mediators Inflamm. 2021; 2021:1267041.
PMID: 34483726 PMC: 8410439. DOI: 10.1155/2021/1267041.
Co-receptor signaling in the pathogenesis of neuroHIV.
Nickoloff-Bybel E, Festa L, Meucci O, Gaskill P Retrovirology. 2021; 18(1):24.
PMID: 34429135 PMC: 8385912. DOI: 10.1186/s12977-021-00569-x.
Sonti S, Sharma A, Tyagi M Virus Res. 2021; 303:198523.
PMID: 34314771 PMC: 8966056. DOI: 10.1016/j.virusres.2021.198523.